Cargando…
Ezrin contributes to cervical cancer progression through induction of epithelial-mesenchymal transition
Cervical cancer is the third most common cancer in females worldwide. The treatment options for advanced cervical cancer are limited, leading to high mortality. Ezrin is a membrane-cytoskeleton-binding protein recently reported to act as a tumor promoter, and we previously indicated that the aberran...
Autores principales: | Kong, Jienan, Di, Chunchan, Piao, Junjie, Sun, Jie, Han, Longzhe, Chen, Liyan, Yan, Guanghai, Lin, Zhenhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4991407/ https://www.ncbi.nlm.nih.gov/pubmed/26933912 http://dx.doi.org/10.18632/oncotarget.7779 |
Ejemplares similares
-
Ezrin promotes breast cancer progression by modulating AKT signals
por: Li, Nan, et al.
Publicado: (2019) -
High expression of ezrin predicts poor prognosis in uterine cervical cancer
por: Kong, Jienan, et al.
Publicado: (2013) -
β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
por: Yang, Yang, et al.
Publicado: (2017) -
Epithelial-Mesenchymal Transition Induces Podocalyxin to Promote Extravasation via Ezrin Signaling
por: Fröse, Julia, et al.
Publicado: (2018) -
Interaction Between Ezrin and Cortactin in Promoting Epithelial to Mesenchymal Transition in Breast Cancer Cells
por: He, Jing, et al.
Publicado: (2017)